Delpha Capital Management’s Bio-Techne TECH Stock Holding History

Delpha Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,076	Closed	-$35K	–	1097
2017 Q4	$35K	Buy	+1,076	New	+$34.2K	0.04%	482

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Delpha Capital Management's TECH Position: Q1 2018 in Review

Delpha Capital Management sold out of Bio-Techne (TECH) in Q1 2018, closing a stake of 1,076 shares — an estimated $35K sold.

Delpha Capital Management first reported a position in TECH in Q4 2017 and held it in 1 quarter. The position peaked at $35K in Q4 2017. 333 funds tracked by Wall St. Rank hold TECH as of Q1 2018.

Delpha Capital Management reported no remaining Bio-Techne position as of Q1 2018 after selling out during the quarter.
Delpha Capital Management sold 1,076 Bio-Techne shares in Q1 2018, an estimated $35K.
Delpha Capital Management first reported a position in Bio-Techne in Q4 2017 and held it in 1 quarter.
Delpha Capital Management's Bio-Techne position peaked at $35K in Q4 2017.
333 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2018.

Based on Delpha Capital Management's 13F filing for Q1 2018, filed 11 May 2018.